These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17846600)

  • 21. Palifermin (Kepivance) for myelotoxic-therapy-related mucositis.
    Med Lett Drugs Ther; 2005 Apr; 47(1207):36. PubMed ID: 15843784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palifermin in children undergoing autologous stem cell transplantation: a matched-pair analysis.
    Czyzewski K; Debski R; Krenska A; Wysocki M; Styczynski J
    Anticancer Res; 2014 Dec; 34(12):7379-82. PubMed ID: 25503176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
    Beaven AW; Shea TC
    Drugs Today (Barc); 2007 Jul; 43(7):461-73. PubMed ID: 17728847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
    Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
    Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation.
    Kim KI; Kim JW; Lee HJ; Kim BS; Bang SM; Kim I; Oh JM; Yoon SS; Lee JS; Park S; Kim BK
    Am J Hematol; 2013 Feb; 88(2):107-12. PubMed ID: 23225026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis.
    Punnett A; Sung L; Price V; Das P; Diezi M; Doyle J; Dupuis LL
    Ther Drug Monit; 2007 Dec; 29(6):750-7. PubMed ID: 18043472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and effects of palifermin for the treatment of oral mucositis in patients affected by acute lymphoblastic leukemia.
    Lucchese A; Matarese G; Ghislanzoni LH; Gastaldi G; Manuelli M; Gherlone E
    Leuk Lymphoma; 2016; 57(4):820-7. PubMed ID: 26428409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).
    Blazar BR; Weisdorf DJ; Defor T; Goldman A; Braun T; Silver S; Ferrara JL
    Blood; 2006 Nov; 108(9):3216-22. PubMed ID: 16835378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
    Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
    Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
    J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study.
    Valcárcel D; Sanz MA; Sureda A; Sala M; Muñoz L; Subirá M; Laborda R; Clopés A; Sierra J
    Bone Marrow Transplant; 2002 May; 29(9):783-7. PubMed ID: 12040477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palifermin: new drug. Prevention of oral mucositis: inappropriate evaluation.
    Prescrire Int; 2007 Aug; 16(90):135-8. PubMed ID: 17724832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
    Ayuk F; Diyachenko G; Zabelina T; Wolschke C; Fehse B; Bacher U; Erttmann R; Kröger N; Zander AR
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):913-9. PubMed ID: 18640575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut protection by palifermin during autologous haematopoietic SCT.
    Johansson JE; Hasséus B; Johansson P; Eklöf C; Ohman D; Stockelberg D
    Bone Marrow Transplant; 2009 May; 43(10):807-11. PubMed ID: 19043460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden.
    Blijlevens N; de Château M; Krivan G; Rabitsch W; Szomor A; Pytlik R; Lissmats A; Johnsen HE; de Witte T; Einsele H; Ruutu T; Niederwieser D;
    Bone Marrow Transplant; 2013 Jul; 48(7):966-71. PubMed ID: 23241739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial.
    Jagasia MH; Abonour R; Long GD; Bolwell BJ; Laport GG; Shore TB; Durrant S; Szer J; Chen MG; Lizambri R; Waller EK
    Bone Marrow Transplant; 2012 Oct; 47(10):1350-5. PubMed ID: 22327131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
    Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune reconstitution and regulation following autologous hematopoietic transplantation using palifermin].
    Pérez-Roca L; Sánchez-Ortega I; Duarte RF
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():15-7. PubMed ID: 21381283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.